Dow Jones U.S. Food & Drug Reta (^DJUSDR)
| Previous Close | 1,222.68 |
| Open | 1,223.60 |
| Volume |
| Day's Range | 1,222.32 - 1,234.87 |
| 52 Week Range | 1,222.32 - 1,234.87 |
| Avg. Volume | N/A |
BloombergA $46 Billion Rally Shows India Tech Woes Easing
(Bloomberg) -- Optimism is returning for India’s information-technology companies as easing odds of a recession in the US and the emergence of artificial intelligence as a potential new source of revenue drive a rebound in their stocks.Most Read from BloombergChina Replaces Foreign Minister After Mysterious Absence‘We Were Wrong’: Morgan Stanley’s Wilson Offers Stocks Mea CulpaTwitter Turning Into X Set to Kill Billions in Brand ValueMusk Explains Why He’s Axing Twitter Name, Iconic Bird LogoWho
ReutersIndia's Infosys cuts FY revenue growth outlook as clients cut spending
BENGALURU (Reuters) -India's No. 2 software services exporter Infosys halved its full-year revenue forecast on Thursday as clients cut back spending and delayed making decisions on future projects in a challenging economic environment. The company, a prominent name in the $245 billion Indian IT industry, cut its full-year revenue growth to 1%-3.5% on a constant currency basis from 4%-7% previously. "We have seen some of the deal signings and start dates being delayed, with that we see a lot of revenue from those large and mega deals towards the later part of the financial year," Infosys CEO Salil Parekh said in a media conference.
